CClinicalTrials.gg
RecruitingNCT06365151Updated Sep 4, 2025

An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia

An interventional study of Osteopathic manual therapy and Sham osteopathic manual therapy in Fibromyalgia and Temporomandibular Disorder, sponsored by Universitat de Lleida. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-04.

Sponsored by Universitat de Lleida · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Nowadays, fibromyalgia is the rheumatic disorder with the highest levels of deterioration in quality of life. Among the comorbidities it presents, one of the most frequent is temporomandibular disorders. A randomized clinical study will be conducted to evaluate the effectiveness of an osteopathic manual therapy approach algorithm in a group of patients with fibromyalgia and temporomandibular disorders.

02

Conditions studied

  • Fibromyalgia
  • Temporomandibular Disorder

Keywords

  • temporomandibular joint disorders
  • fibromyalgia
  • Osteopathic medicine
  • chronic pain
  • musculoskeletal manipulations
03

In context

Fibromyalgia

1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.

This study's planned enrollment of 114 is above the median of 60 across 1,035 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Universitat de Lleida is the lead sponsor of 33 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • be diagnosed as suffering from fibromyalgia,
  • present moderate pain or dysfunction of more than 3 months' duration in the temporomandibular joint,
  • be over 18 years old,
  • understand Spanish and/or Catalan correctly,
  • and read and accept the informed consent form

Exclusion criteria

Exclusion Criteria:

  • history of trauma or recent surgery to the head, face or neck;
  • systemic, rheumatic or central nervous system diseases;
  • diagnosis of malignant tumors or cancer in the orofacial region;
  • participate in other studies at the same time.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
114 participants (estimated)

Study arms

  • Experimental
    experimental

    treatment will be carried out following a previously validated approach algorithm. Articulatory techniques, soft tissue mobilization techniques, trigger point inhibition, etc. will be used.

    Other: Osteopathic manual therapy

  • Sham comparator
    sham

    A sham treatment will be performed following a previously validated approach algorithm. techniques will be simulated in such a way that they will have no therapeutic effect.

    Other: Sham osteopathic manual therapy

Interventions

  • OtherOsteopathic manual therapy

    osteopathic manual treatment aimed at improving the function and pain of the temporomandibular joint.

  • OtherSham osteopathic manual therapy

    a sham osteopathic manual treatment without therapeutic effect

06

What researchers measure

Primary outcomes

  1. catastrophizing

    The Pain Catastrophizing scale (PCS), evaluates the degree og catastrophic thinking gdue to pain.It is a 13-item scale, with a total range from 0 to 52. Higher scores are associated with a greater degree of pain catastrophizing.

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. functional limitation

    evaluated with tue short version of the Jaw functional limitation scale (JFLS-8). Evaluates the functional status of the masticatory system. Questionnaire with 8 items, each with a scale from 0 to 10. A higher score suggests a greater limitation.

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. functional status, disability and pain

    collected in the craniofacial pain and disability inventory (CFPDI). Self administered questionnaire of 21 items. Each item is scored on a Likert scale from 0 to 3.

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. pain and tinnitus

    evaluated with a visual analog scale (VAS). Scale from 0 to 10, where 0 indicates no pain and 10 the worst pain imaginable.

    Time frame: From enrollment to the end of treatment at 6 weeks

  5. myofascial trigger points

    presence of a palpable tight band, presence of a hyperirritable tenderpoint within te tight band, local twitch response elicited by acute palpation of the tight band, and presence refered pain in response ot trigger point compression.

    Time frame: From enrollment to 4 weeks

  6. Range of motion

    measurements taken with a ruler: maximum opening, maximun active opening without pain and lateralization.

    Time frame: From enrollment to 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Osteopatia i Fisioteràpia Cornellà
    Cornellà de Llobregat, Barcelona 08940, Spain
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06365151
Lead sponsor
Universitat de Lleida
Responsible party
Llanos de la Iglesia (Principal investigator, Universitat de Lleida) — Principal investigator
First posted
Apr 15, 2024
Start date
Apr 5, 2024
Primary completion
Jul 31, 2025
Completion
Apr 5, 2026 (estimated)
Last update
Sep 4, 2025

Study contacts

Llanos de la Iglesia, MsC
Contact
llanos.delaiglesia@gmail.com
+4679536992
Llanos de la Iglesia
Contact
llanos.delaiglesia@gmail.com
+34679536992
Llanos de la Iglesia
principal investigator · Departament de infermeria i fisioterapia. universitat de Lleida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion